LEAH Labs
Human's best science for human's best friend 👨🏻🔬 🧬 🐶
Last Funded July 2021
Pitch Video
Investor Panel
Highlights
Y Combinator
Raised from Y Combinator
1
🐕We’re developing a cost effective cell therapy to cure cancer in dogs. It's proven in humans.
2
🐶Your funding goes DIRECTLY to our pilot trials in dogs with cancer
3
$150,000+ committed outside Wefunder during this round
4
🐩Awarded $394,000 in grant funding to date, including a National Science Foundation Phase I SBIR
Our Team
Chief Executive Officer
Genome hacker. Layla the mutt's dad. Gene editor since 2011. PhD in Molecular, Cellular, and Developmental Biology.
Dogs are part of the family and we don't feel that the current care they get is up to par; they deserve the same technological advances in healthcare that their humans get. Using our expertise in gene editing, we can bring innovation to the veterinary market that has never before been possible.
Alex AbelVP of Cell Biology
PhD in immunology. Rosie the Burnese's dad. Author of Natural Killer cell review read by nearly 100k scientists to date. Former technical sales at Miltenyi, world leader in cell biology applications.
Scientific Founder - Immunotherapy
Physician scientist, hematologist, expert/inventor in CAR-T cell therapy. Developed tech for the first CAR-T IND approval at his institution. Assistant Professor, Medicine, Oncology
We're using human's best science for human's best friend
LEAH Labs is the first company utilizing gene editing to engineer living therapies for dogs. Using our proprietary technology, we give living cells the genetic information to seek out and destroy cancer.
We’re using human’s best science, for human’s best friend.